Literature DB >> 21252265

Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum.

Masafumi Ito1, Kenjiro Matsuno, Yasuhiko Sakumoto, Koichi Hirata, Nobuhiro Yuki.   

Abstract

BACKGROUND: Ataxic Guillain-Barré syndrome is characterised by profound ataxia with negative Romberg sign and no ophthalmoplegia. Its nosological relationship to acute sensory ataxic neuropathy has yet to be discussed.
METHODS: Medical records were reviewed of patients suffering acute ataxia and reduced muscle stretch reflexes but without external ophthalmoplegia. Clinical features and laboratory findings were analysed. Rat muscle spindles were immunostained by anti-GQ1b and -GD1b antibodies.
RESULTS: The Romberg sign was negative in 37 (69%) of 54 patients with acute ataxic neuropathy without ophthalmoplegia, but positive in the other 17 (31%). The negative and positive subgroups had similar features; preceding infectious symptoms (86% vs 83%), distal paraesthesias (70% vs 88%), superficial sense impairment (27% vs 24%), IgG antibodies to GQ1b (65% vs 18%) and GD1b (46% vs 47%) and cerebrospinal fluid albuminocytological dissociation (30% vs 39%). Findings did not differ between the subgroups of 466 patients with Fisher syndrome with and without sensory ataxia. Acute ataxic neuropathy patients more often had anti-GD1b (46% vs 26%) and less often anti-GQ1b (50% vs 83%) antibodies than Fisher syndrome. Anti-GQ1b and -GD1b antibodies strongly stained parvalbumin-positive nerves in rat muscle spindles, indicative that proprioceptive nerves highly express GQ1b and GD1b.
CONCLUSION: Clinical and laboratory features suggest that ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. The two conditions could be comprehensively referred to as 'acute ataxic neuropathy (without ophthalmoplegia)' to avoid nosological confusion because Fisher syndrome is not classified by the absence or presence of sensory ataxia. That is, acute ataxic neuropathy can be positioned as an incomplete form of Fisher syndrome.

Entities:  

Mesh:

Year:  2011        PMID: 21252265     DOI: 10.1136/jnnp.2010.222836

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia.

Authors:  Nobuhiro Yuki; Yuki Fukami; Chiaki Yanaka; Saiko Koike; Koichi Hirata
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

2.  A case report of Fisher syndrome with the detection of anti-GM3 and anti-GD1b IgG antibodies.

Authors:  Kosuke Matsuzono; Tadashi Ozawa; Keisuke Yoshikawa; Susumu Kusunoki; Shigeru Fujimoto
Journal:  Neurol Sci       Date:  2018-11-23       Impact factor: 3.307

3.  Acute ataxic neuropathy with hyperreflexia.

Authors:  Leonard L L Yeo; Kay Ng; Nobuhiro Yuki
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

4.  Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.

Authors:  Keiichiro Susuki; Nobuhiro Yuki; Dorothy P Schafer; Koichi Hirata; Gang Zhang; Kei Funakoshi; Matthew N Rasband
Journal:  Exp Neurol       Date:  2011-12-08       Impact factor: 5.330

5.  Clinical Reasoning: An 8-Year-Old With Acute Onset Ataxia.

Authors:  John Robert McLaren; Matthew Kyler Mitchell; Fatima Mohamed Al-Maadid; Kevin Joseph Staley
Journal:  Neurology       Date:  2022-06-03       Impact factor: 11.800

Review 6.  'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 7.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

Review 8.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 9.  Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.

Authors:  Melvin Berger; Daniel E McCallus; Cindy Shin-Yi Lin
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

Review 10.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.